Podcast: Non-binding Guidance: SEC Disclosure Issues for Life Sciences Companies
On January 18, 2024, New York’s Appellate Division rejected a junior mezzanine lender’s contention that it was fraudulently induced to amend the parties’ intercreditor agreement, because it failed to identify specific...more